肿瘤相关脑梗死发病机制的研究进展

doi:10.3969/j.issn.1673-5765.2021.02.003

摘要/Abstract

摘要：

肿瘤相关脑梗死的发病机制复杂，且肿瘤相关机制和多种传统机制共同参与脑梗死的发生。在肿瘤相关性卒中病因中，肿瘤的直接作用、凝血功能异常、非细菌性血栓性心内膜炎、感染和内皮损伤等机制都与肿瘤直接相关；而化疗、放疗、内分泌治疗和侵入性治疗等针对肿瘤的治疗也可通过相关的病理生理学机制引起脑梗死的发生。不同病理生理学机制相互交叉，共同导致了脑梗死的发生。

文章导读： 肿瘤相关脑梗死可能有多种机制共同参与，其中凝血功能异常、内皮损伤和肿瘤相关治疗占有更为重要的地位，对肿瘤患者脑梗死的预防和治疗有一定的参考价值。

关键词: 肿瘤; 脑梗死; 发病机制

Abstract:

The pathogenesis of cancer-associated ischemic stroke is complicated, and cancerassociated mechanisms and a variety of traditional mechanisms are jointly involved in the occurrence of ischemic stroke. The mechanisms directly related to cancer include the direct effect of cancer, abnormal blood coagulation, nonbacterial thrombotic endocarditis, infection and endothelial cell injury; in addition, the cancer treatment, including chemotherapy, radiotherapy, endocrine therapy and invasive treatment, can also cause stroke through related pathophysiological mechanism. Some pathophysiological mechanisms interact each other and jointly contribute to the occurrence of ischemic stroke.

Key words: Cancer; Ischemic stroke; Pathogenesis

杨启舟，付睿，王莉莉. 肿瘤相关脑梗死发病机制的研究进展[J]. 中国卒中杂志, 2021, 16(02): 124-129.

YANG Qi-Zhou, FU Rui, WANG Li-li. Pathogenesis of Cancer-Associated Ischemic Stroke[J]. Chinese Journal of Stroke, 2021, 16(02): 124-129.

参考文献

[1] YOUNG B O，MYOUNG S J，GYEONG K S，et al.

Ischemic stroke and cancer：stroke severely impacts

cancer patients，while cancer increases the number

of strokes[J]. J Clin Neurol，2011，7（2）：53-59.

[2] ZÖLLER B，JI J，SUNDQUIST J，et al. Risk of

haemorrhagic and ischaemic stroke in patients

with cancer：a nationwide follow-up study from

Sweden[J]. Eur J Cancer，2012，48（12）：1875-1883.

[3] BUDINCEVIC H，PIRŠIC A，BOHM T，et al.

Carotid body tumor as a cause of stroke[J]. Intern

Med，2016，55（3）：295-298.

[4] BARGHOUTHI T，GIUGLIANO A，KIMSHAPIRO

J W L，et al. Pearls & Oy-sters：Ⅳ and

mechanical thrombolysis for ischemic stroke

secondary to cardiac myxoma[J]. Neurology，2019，

93（22）：975-977.

[5] ZHENG Z，GUO G J，XU L，et al. Left atrial

myxoma with versus without cerebral embolism：

length of symptoms，morphologic characteristics，

and outcomes[J]. Texas Heart Inst J，2014，41（6）：

592-595.

[6] STERGIOPOULOS K，VASU S，BILFINGER T，et

al. Embolic stroke in a patient with metastatic renal

cell cancer[J]. Hellenic J Cardiol，2011，52（3）：

256-258.

[7] DIMITROVI? A，BREITENFELD T，SUPANC V，

et al. Stroke caused by lung cancer invading the left

atrium[J/OL]. J Stroke Cerebrovasc Dis，2016，25

（5）：e66-e68[2020-10-08]. https：//doi.org/10.1016/j.

jstrokecerebrovasdis.2015.12.043.

[8] COLLINS R C，AL-MONDHIRY H，CHERNIK

N L，et al. Neurologic manifestations of

intravascular coagulation in patients with cancer. A

clinicopathologic analysis of 12 cases[J]. Neurology，

1975，25（9）：795-806.

[9] KIM S G，HONG J M，KIM H Y，et al. Ischemic

stroke in cancer patients with and without

conventional mechanisms：a multicenter study in

Korea[J]. Stroke，2010，41（4）：798-801.

[10] KARLI?SKA A G，GROMADZKA G，

KARLI?SKI M A，et al. The activity of malignancy

may determine stroke pattern in cancer patients[J]. J

Stroke Cerebrovasc Dis，2015，24（4）：778-783.

[11] SCHWARZBACH C J，SCHAEFER A，EBERT A，

et al. Stroke and cancer：the importance of cancerassociated

hypercoagulation as a possible stroke

etiology[J]. Stroke，2012，43（11）：3029-3034.

[12] DEARBORN J L，URRUTIA V C，ZEILER S R.

Stroke and cancer- a complicated relationship[J]. J

Neurol Transl Neurosci，2014，2（1）：1039.

[13] SELVIK H A，THOMASSEN L，LOGALLO N，et

al. Prior cancer in patients with ischemic stroke：the

Bergen NORSTROKE study[J]. J Stroke Cerebrovasc

Dis，2014，23（5）：919-925.

[14] LEE A Y. Cancer and thromboembolic disease：

pathogenic mechanisms[J]. Cancer Treat Rev，2002，

28（3）：137-140.

[15] FRANCO A T，CORKEN A，WARE J. Platelets

at the interface of thrombosis，inflammation，and

cancer[J]. Blood，2015，126（5）：582-588.

[16] PENG Z K，SHU B Y，ZHANG Y R，et al.

Endothelial response to pathophysiological stress[J/

OL]. Arterioscler Thromb Vasc Biol，2019，39（11）：

e233-e243[2020-10-08]. https：//doi.org/10.1161/

atvbaha.119.312580.

[17] NAVI B B，REINER A S，KAMEL H，et al.

Association between incident cancer and subsequent

stroke[J]. Ann Neurol，2015，77（2）：291-300.

[18] LEFKOVITZ N W，ROESSMANN U，KORI S H.

Major cerebral infarction from tumor embolus[J].

Stroke，1986，17（3）：555-557.

[19] OJEDA V J，FROST F，MASTAGLIA F L. Nonbacterial

thrombotic endocarditis associated with

malignant disease：a clinicopathological study of 16

cases[J]. Med J Aust，1985，142（12）：629-631.

[20] GLASS J P. The diagnosis and treatment of stroke

in a patient with cancer：nonbacterial thrombotic

endocarditis（NBTE）：a case report and review[J].

Clin Neurol Neurosurg，1993，95（4）：315-318.

[21] ROYTER V，COHEN S N. Recurrent embolic

strokes and cardiac valvular disease in a patient with

non-small cell adenocarcinoma of lung[J]. J Neurol

Sci，2006，241（1/2）：99-101.

[22] STEINER I. Nonbacterial thrombotic endocarditis-a

study of 171 case reports[J]. Cesk Patol，1993，29（2）：

58-60.

[23] EDOUTE Y，HAIM N，RINKEVICH D，et al.

Cardiac valvular vegetations in cancer patients：a

prospective echocardiographic study of 200

patients[J]. Am J Med，1997，102（3）：252-258.

[24] LIU J，FRISHMAN W H. Nonbacterial thrombotic

endocarditis：pathogenesis，diagnosis，and

management[J]. Cardiol Rev，2016，24（5）：244-247.

[25] ZEMBOWER T R. Epidemiology of infections in

cancer patients[J/OL]. Cancer Treat Res，2014，161：

43-89[2020-10-08]. https：//doi.org/10.1007/978-3-

319-04220-6_2.

[26] BOS M M E M，SMEETS L S，DUMAY I，et al.

Bloodstream infections in patients with or without

cancer in a large community hospital[J]. Infection，

2013，41（5）：949-958.

[27] FRIEDL P，ALEXANDER S. Cancer invasion and

the microenvironment：plasticity and reciprocity[J].

Cell，2011，147（5）：992-1009.

[28] ELKIND M S V. Inflammatory mechanisms of

stroke[J/OL]. Stroke，2010，41（10 Suppl）：S3-

8[2020-10-08]. https：//doi.org/10.1161/strokeaha.

110.594945.

[29] FUGATE J E，LYONS J L，THAKUR K T，et al.

Infectious causes of stroke[J]. Lancet Infect Dis，

2014，14（9）：869-880.

[30] SAYNAK M，COSAR-ALAS R，YURUTCALOGLU

V，et al. Chemotherapy and

cerebrovascular disease[J]. J BUON，2008，13（1）：

31-36.

[31] WALL J G，WEISS R B，NORTON L，et al. Arterial

thrombosis associated with adjuvant chemotherapy

for breast carcinoma：a cancer and leukemia group B

study[J]. Am J Med，1989，87（89）：501-504.

[32] DE CELIS E，ALONSO DE LECIÑANA M，

RODRÍGUEZ-PARDO J，et al. Increased risk of

ischemic stroke in multiple myeloma associated with

lenalidomide treatment：a case report and review of

the literature[J]. Clin Neuropharmacol，2018，41（6）：

232-235.

[33] ROBINSON D，GARMO H，LINDAHL B，et al.

Ischemic heart disease and stroke before and during

endocrine treatment for prostate cancer in PCBaSe

Sweden[J]. Int J Cancer，2012，130（2）：478-487.

[34] MOSCA L，GRADY D，BARRETT-CONNOR

E，et al. Effect of raloxifene on stroke and venous

thromboembolism according to subgroups in

postmenopausal women at increased risk of coronary

heart disease[J]. Stroke，2009，40（1）：147-155.

[35] ESTEVA F J，HORTOBAGYI G N. Comparative

assessment of lipid effects of endocrine therapy

for breast cancer：implications for cardiovascular

disease prevention in postmenopausal women[J].

Breast，2006，15（3）：301-312.

[36] YANG T L，WU T C，HUANG C C，et al.

Association of tamoxifen use and reduced

cardiovascular events among Asian females with

breast cancer[J]. Circ J，2014，78（1）：135-140.

[37] AZOULAY L，YIN H，BENAYOUN S，et al.

Androgen-deprivation therapy and the risk of stroke

in patients with prostate cancer[J]. Eur Urol，2011，

60（6）：1244-1250.

[38] JESPERSEN C G，NØRGAARD M，BORRE

M. Androgen-deprivation therapy in treatment of

prostate cancer and risk of myocardial infarction and

stroke：a nationwide Danish population-based cohort

study[J]. Eur Urol，2014，65（4）：704-709.

[39] LIU R L，ZHOU J T，XIA S，et al. Androgen

deprivation therapy and the risk of stroke in patients

with prostate cancer：an updated systematic review

and meta-analysis[J]. Urol Int，2020，104（3/4）：

214-221.

[40] CHUNG S D，CHEN Y K，WU F J，et al. Hormone

therapy for prostate cancer and the risk of stroke：a

5-year follow-up study[J]. BJU Int，2012，109（7）：

1001-1005.

[41] TAE B S，JEON B J，CHOI H，et al. Is androgen

deprivation therapy associated with cerebral

infarction in patients with prostate cancer? A Korean

nationwide population-based propensity score

matching study[J]. Cancer Med，2019，8（9）：4475-

4483.

[42] SCOTT A S，PARR L A，JOHNSTONE P A.

Risk of cerebrovascular events after neck and

supraclavicular radiotherapy：a systematic review[J].

Radiother Oncol，2009，90（2）：163-165.

[43] STEWART F A，HOVING S，RUSSELL N S，et

al. Vascular damage as an underlying mechanism

of cardiac and cerebral toxicity in irradiated cancer

patients[J]. Radiat Res，2010，174（6）：865-869.

[44] DORRESTEIJN L D，KAPPELLE A C，BOOGERD

W，et al. Increased risk of ischemic stroke after

radiotherapy on the neck in patients younger than 60

years[J]. J Clin Oncol，2002，20（1）：282-288.

[45] HUNG S K，LEE M S，CHIOU W Y，et al. High

incidence of ischemic stroke occurrence in irradiated

lung cancer patients：a population-based surgical

cohort study[J/OL]. PLoS One，2014，9（4）：

e94377[2020-10-08]. https：//doi.org/10.1371/journal.

pone.0094377.

[46] MUELLER S，FULLERTON H J，STRATTON K，

et al. Radiation，atherosclerotic risk factors，and

stroke risk in survivors of pediatric cancer：a report

from the childhood cancer survivor study[J]. Int J

Radiat Oncol Biol Phys，2013，86（4）：649-655.

[47] 李真，武丹娜. 恶性肿瘤合并缺血性卒中的研究进

展[J]. 临床荟萃，2016，31（7）：809-812.

[48] YAMAMOTO T，SUZUKI H，NAGATO K，et al.

Is left upper lobectomy for lung cancer a risk factor

for cerebral infarction?[J]. Surg Today，2016，46（7）：

780-784.

[49] KAMIYA-MATSUOKA C，CACHIA D，YUSTKATZ

S，et al. Ischemic stroke in patients with

gliomas at the University of Texas-M. D. Anderson

Cancer Center[J]. J Neurooncol，2015，125（1）：143-

148.